Tag: Centogene N.V.
-
Advancing Precision Medicine: CENTOGENE and Lifera’s Strategic Collaboration and $30M Investment
The biopharma landscape is witnessing a significant transformation, with strategic collaborations and investments, aimed at furthering precision medicine. The recent strategic alliance between global multiomic testing leader, CENTOGENE, and Lifera, a biopharma company owned by the Public Investment Fund (PIF), serves as a testament to this. The collaboration heralds a new era of advanced healthcare…